Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Blood|June 20, 2020
Optimized tandem CD19/CD20 CAR-engineered T cells in refractory/relapsed B-cell lymphomaChuan Tong, Yajing Zhang, Yang Liu, et al.Journal of Hematology & Oncology|May 20, 2020
Correction to: Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemiaHanren Dai, Zhiqiang Wu, Hejin Jia, et al.Signal Transduction and Targeted Therapy|March 18, 2026
DUSP6 ablation restores CAR T-cell fitness impaired by tumor CD58 loss through invigoration of AP-1 signalingXinran Ma, Yang Zhang, Yao Wang, et al.Oncoimmunology|June 15, 2018
CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trialYao Wang, Meixia Chen, Zhiqiang Wu, et al.Nature Communications|January 19, 2021
Low-dose decitabine priming endows CAR T cells with enhanced and persistent antitumour potential via epigenetic reprogrammingYao Wang, Chuan Tong, Hanren Dai, et al.Nature Communications|April 15, 2026
Demethylation-primed tandem CD19/CD20 CAR T cells in relapsed/refractory B-cell lymphoma: a phase I/II trialChunmeng Wang, Yelei Guo, Fuxin Han, et al.Oncoimmunology|October 10, 2015
Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemiaHanren Dai, Wenying Zhang, Xiaolei Li, et al.Journal of Hematology & Oncology|November 27, 2016
Co-infusion of haplo-identical CD19-chimeric antigen receptor T cells and stem cells achieved full donor engraftment in refractory acute lymphoblastic leukemiaBo Cai, Mei Guo, Yao Wang, et al.Pageof 4